Rheinmetall AG 27.04.2015 13:47 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- On April 24, 2015, UBS AG, Zürich, Switzerland has informed us according to Article 21, Section 1 of the WpHG that via shares its Voting Rights on Rheinmetall AG, Düsseldorf, Germany, have fallen below the 3% threshold of the Voting Rights on April 20, 2015 and on that day amounted to 2.33% (this corresponds to 921815 Voting Rights). 0.84% of Voting Rights (this corresponds to 333230 Voting Rights) are attributed to the company in accordance with Article 22, Section 1, Sentence 1, No. 1 of the WpHG (German Securities Trading Act). 27.04.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Rheinmetall AG Rheinmetall Platz 1 40476 Düsseldorf Germany Internet: www.rheinmetall.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-PVR: Rheinmetall AG: Release according to Article 26,
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Market Expansion of Utility Solar Trackers: Future Insights
Utility Solar Tracker Market Growth Prospects The utility solar tracker market is projected to reach an impressive USD 34.6 billion in the coming years. This growth is largely driven by the declining costs of photovoltaic (PV) panels, which have significantly lowered the financial barriers for solar energy projects. As PV panels become more affordable, the opportunity for...
Continue Reading
UVA Cancer Center Joins Caris Precision Oncology Alliance
UVA Cancer Center Joins the Caris Precision Oncology Alliance UVA Cancer Center has officially joined the Caris Precision Oncology Alliance (Caris POA), a significant network dedicated to advancing precision medicine and cancer treatment. Caris Life Sciences is thrilled to welcome this esteemed institution, recognized for its commitment to enhancing patient outcomes...
Continue Reading
Investors Show Strong Confidence in Spotify Technology's Future Potential
High-Rolling Investors Stake Their Bets on Spotify Technology In recent developments, it's evident that significant investors have adopted a bullish stance on Spotify Technology. This movement warrants attention from retail traders and those interested in stock market dynamics. Overview of Options Activity Tracking the latest trends, we've noted a remarkable surge in...
Continue Reading
Johnson & Johnson's Groundbreaking CAR T-Cell Therapy Data Unveiled
Johnson & Johnson’s CAR T-Cell Therapy Demonstrates Promise in Lymphoma In a recent Phase 1b study, Johnson & Johnson (NYSE: JNJ) revealed the first clinical results of its investigational dual-targeting CAR T-cell therapy, JNJ-90014496, specifically aimed at treating patients with relapsed or refractory large B-cell lymphoma (R/R LBCL). This early data suggests a...
Continue Reading
Booking Holdings Prepares for Upcoming Earnings Report
Booking Holdings Set for Earnings Announcement Booking Holdings (NASDAQ: BKNG) is gearing up to share its quarterly earnings. Investors are keenly awaiting this announcement, which is expected to be significant for market sentiment and share price movements. Expected Earnings Per Share According to analysts, Booking Holdings is projected to report an impressive earnings...
Continue Reading